[Molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria: a role of NKG2D-medicated immunity].
Kawaguchi
Tatsuya
T
D000741:Anemia, Aplastic / Q000235:genetics / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D015551:Autoimmunity; D001855:Bone Marrow Diseases / Q000235:genetics / Q000276:immunology*; D006410:Hematopoiesis; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D055655:NK Cell Lectin-Like Receptor Subfamily K / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C527085:KLRK1 protein, human; D008565:Membrane Proteins; D055655:NK Cell Lectin-Like Receptor Subfamily K; C080086:phosphatidylinositol glycan-class A protein; C481642:eculizumab